You are here

Article Text

Article menu
Download PDFPDF
Endoscopy news
Patient-reported experience of colonoscopy in Italy: a multicentre prospective observational study
  1. Lorenzo Fuccio1,2,
  2. Colin J Rees3,
  3. Leonardo Frazzoni1,2,
  4. Laura Neilson4,
  5. Franco Radaelli5,
  6. Linda Sharp6,
  7. Cesare Hassan7,
  8. Cristiano Spada8,9
  9. The ENDOPREM Study Group
    1. 1 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
    2. 2 IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S Orsola-Malpighi, Bologna, Italy
    3. 3 Gastroenterology, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK
    4. 4 South Tyneside District Hospital, South Shields, UK
    5. 5 Gastroenterology Unit, Valduce Hospital, Como, Italy
    6. 6 Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
    7. 7 Humanitas Group, Rozzano, Italy
    8. 8 Fondazione Policlinico Universitario A. Gemelli IRCCS, Digestive Endoscopy Unit, Rome, Italy
    9. 9 Università Cattolica del Sacro Cuore, Centre for Endoscopic Research Therapeutics and Training (CERTT), Rome, Italy
    1. Correspondence to Dr Lorenzo Fuccio, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; lorenzofuccio{at}gmail.com

    https://doi.org/10.1136/gutjnl-2023-330415

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Message

      Patient experience is one of the major quality indicators that should be routinely measured before, during and after a colonoscopy, however, there is no consensus about how to measure it. The Newcastle ENDOPREM is a recently developed comprehensive patient-reported experience measurement (PREM) for endoscopic procedures, which has been solely validated and used in the UK. We present the first clinical experience of assessing patient experience with the Newcastle ENDOPREM outside the UK, in a large, multicentre, prospective study. The questionnaire, designed for self-completion, is composed of seven sections largely structured to follow the temporal phases of the process: before, during and after the examination. After including 1625 patients, the established target level of 90% threshold of patients reporting positive experience for each item was only reached in 10/25 (40%) of the items before, 7/14 (50%) of the items during and 3/6 (50%) of the items after the examination. Women with no history of previous colonoscopies and with a basic education were more likely to have a negative experience overall (OR 1.83; 95% CI 1.34 to 2.32). The Newcastle ENDOPREM was easily adopted in a context other than the UK and its implementation in daily practice should help to introduce tailored interventions aimed at improving colonoscopy practice as well as information and education regarding colonoscopy, with special attention to well-defined subgroups of patients.

      In more details

      Colonoscopy is the gold standard for investigation of the lower gastrointestinal tract, for diagnosing and treating colonic diseases.1 Along with physical stress, anxiety and psychological discomfort are frequently reported by patients, as well as a fear of feeling pain or embarrassment during the procedure.2–4 All of these concerns can lead to a decline in patient compliance and satisfaction and reduce participation in screening programmes and adversely affect reattendance for surveillance procedures.5

      Therefore, patient experience is now …

      View Full Text

      Footnotes

      • Twitter @BottProf

      • Collaborators The ENDOPREM Study Group (alphabetical order): Emilio Barbera, Alessandro Benini, Lorenzo Carloni, Valentina Di Giorgio, Marina La Marca, Liboria Laterza, Valentina Paci, Chiara Pierantoni, Antonella Santolupo Elena Toppi, Rocco Maurizio Zagari (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Department of Medical and Surgical Sciences, Gastroenterology Unit, University of Bologna, Bologna, Italy); Cecilia Binda, Carlo Fabbr, Giulia Gibino, Monica Sbrancia, (Unit of Gastroenterology and Digestive Endoscopy, Forli-Cesena Hospital, AUSL Romagna, Forli-Cesena, Italy), Alberto Fantin; Daniela Velo (Istituto Oncologico Veneto IOV-IRCCS, Gastroenterology Unit, Padova, Italy), Pietro Fusaroli, Andrea Lisotti (Gastroenterology Unit, Hospital of Imola, University of Bologna, Imola, Italy), Alessandro Mussetto (Gastroenterology Unit, S. Maria delle Croci Hospital, Ravenna, Italy), Giacomo Tamanini (Gastroenterology Unit, Valduce Hospital, Como, Italy).

      • Contributors Study concept and design: LFu and CS. ENDOPREM development: CJR, LN and LS; Data management and statistical analysis: LFu and LFr. Data interpretation: LFu, CJR, LFr, LN, FR, LS, CH and CS. Drafting the manuscript: LFu, CJR, LFr, LN, FR and LS. Critical revision of manuscript for important intellectual content: CJR, LN, FR, LS and CH. Data acquisition: ENDOPREM Study Group. Final Approval of the paper: all the authors.

      • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

      • Competing interests None declared.

      • Provenance and peer review Not commissioned; internally peer reviewed.

      • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.